NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia

Not Applicable

Completed

Conditions: Paroxysmal Hypertension
Dysthymia
Anxiety Disorders
Familial Dysautonomia
Autosomal Recessive Disease

Interventions: Behavioral: 8-week CBT Program

First Posted Date: 2017-01-06

Last Posted Date: 2019-01-29

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT03013777

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Brief CBT for the Treatment of Depression During Inpatient Hospitalization

Not Applicable

Withdrawn

Conditions: Depression

Interventions: Behavioral: Usual Standard of Care
Behavioral: Cognitive Behavioral Therapy Condition (CBT)

First Posted Date: 2017-01-05

Last Posted Date: 2019-03-26

Lead Sponsor: NYU Langone Health

Registration Number: NCT03011619

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Integrating Community Health Workers to Improve Diabetes Prevention

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Data Only
Behavioral: CHW Training

First Posted Date: 2016-12-30

Last Posted Date: 2022-06-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 773

Registration Number: NCT03006666

Locations: 🇺🇸
New York University Medical Center, New York, New York, United States

The GEM (Goals for Eating and Moving) Study

Not Applicable

Completed

Conditions: Obesity
Weight Gain

Interventions: Behavioral: Enhanced Usual Care
Behavioral: GEM

First Posted Date: 2016-12-30

Last Posted Date: 2023-04-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 489

Registration Number: NCT03006328

Locations: 🇺🇸
New York University Medical Center Institutional Review Boards, New York, New York, United States

Adapting Project UPLIFT for Hispanic Patients With Epilepsy II

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Behavioral: Using Practice and Learning to Increase Favorable Thoughts
Behavioral: Usual Care

First Posted Date: 2016-12-22

Last Posted Date: 2020-05-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 72

Registration Number: NCT03000725

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Aerobic Exercise and Aphasia Treatment

Not Applicable

Completed

Conditions: Aphasia

Interventions: Behavioral: Language therapy
Behavioral: Background Music
Behavioral: Aerobic Exercise

First Posted Date: 2016-12-21

Last Posted Date: 2024-11-11

Lead Sponsor: NYU Langone Health

Target Recruit Count: 8

Registration Number: NCT02999360

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Mechanistic Effects of Colchicine in Patients With Myocardial Infarction

Phase 4

Withdrawn

Conditions: Myocardial Infarction

Interventions: Drug: Colchicine 0.6 mg tablets

First Posted Date: 2016-12-16

Last Posted Date: 2019-04-18

Lead Sponsor: NYU Langone Health

Registration Number: NCT02995512

Comparison of Medical and Surgical Treatment of Uncomplicated Acute Appendicitis in Children

Phase 4

Completed

Conditions: Appendicitis

Interventions: Drug: Piperacillin/Tazobactam
Procedure: Surgical Treatment

First Posted Date: 2016-12-14

Last Posted Date: 2022-01-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 39

Registration Number: NCT02991937

Locations: 🇺🇸
New York University, New York, New York, United States

A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 2

Completed

Conditions: Substance Abuse

First Posted Date: 2016-12-08

Last Posted Date: 2019-01-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 72

Registration Number: NCT02986841

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Phase 1

Completed

Conditions: Melanoma

Interventions: Biological: DS-8273a
Biological: Nivolumab

First Posted Date: 2016-12-06

Last Posted Date: 2021-10-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT02983006

Locations: 🇺🇸
Laura and Isaac Perlmutter Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy